CI

At a glance

ClinicalIndex Comparison Record
N/AActive· 1,242 enrolled
Drug / intervention
Portico transcatheter aortic valve +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02000115
NCT02000115N/AActive
CompareCT.gov

Portico Re-sheathable Transcatheter Aortic Valve System US IDE Trial

Abbott Medical Devices·interventional·Posted Dec 3, 2013·Updated Jul 20, 2025

In Brief

A clinical study evaluating Portico transcatheter aortic valve and Commercially available transcatheter aortic valve for Aortic Valve Stenosis. Active but no longer recruiting, targeting 1,242 participants across 70 sites in 2 countries.

Detailed Summary

The objective of the PORTICO pivotal IDE trial is to evaluate the safety and effectiveness of the St Jude Medical (SJM) Portico Transcatheter Heart Valve and Delivery Systems (Portico) in the treatment of severe symptomatic aortic stenosis via transfemoral and alternative delivery methods in high risk and extreme risk patients.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAortic Valve Stenosis
CountriesAustralia, United States
Collaborators--

Timeline

N/AActive
20142015201620172018201920202021202220232024202520262027
First PostedDec 3, 2013
Enrollment StartMay 1, 2014
Primary CompletionOct 1, 2019
Study CompletionDec 1, 2026
TodayJul 2, 2026
Enrollment to primary: 5.4 yearsPosted 12.6 years ago

Interventions

Portico transcatheter aortic valvedevice

St. Jude Medical transcatheter Portico aortic valve

Commercially available transcatheter aortic valvedevice

Commercially available transcatheter aortic valve